Yeast genomics and proteomics in drug discovery and target validation
- PMID: 14593709
Yeast genomics and proteomics in drug discovery and target validation
Abstract
Small, cell permeable, and target-specific chemical ligands are highly valuable, not only as therapeutics but also as research tools. The synthesis, identification and characterization of these compounds is often a difficult task. The straightforward genetics of the budding yeast Saccharomyces cerevisiae, and the high degree of conservation of basic cellular processes between yeast and higher organisms makes yeast an excellent tool for drug development studies, particularly in regards to anticancer and anti-fungal drug discovery. Recent advances in yeast functional genomics and proteomics studies are changing the field of yeast research. Many of these new technologies are readily applicable to drug target identification and other aspects of drug discovery. This review will focus on current genetic, genomic, and proteomic methodologies in S. cerevisiae that have the potential to be useful in drug discovery and target validation.
Similar articles
-
From drug to protein: using yeast genetics for high-throughput target discovery.Curr Opin Chem Biol. 2005 Feb;9(1):20-4. doi: 10.1016/j.cbpa.2004.12.001. Curr Opin Chem Biol. 2005. PMID: 15701448 Review.
-
[Development of antituberculous drugs: current status and future prospects].Kekkaku. 2006 Dec;81(12):753-74. Kekkaku. 2006. PMID: 17240921 Review. Japanese.
-
Yeast and drug discovery.Funct Integr Genomics. 2002 Sep;2(4-5):199-211. doi: 10.1007/s10142-002-0059-1. Epub 2002 May 31. Funct Integr Genomics. 2002. PMID: 12192593 Review.
-
Yeast on drugs: Saccharomyces cerevisiae as a tool for anticancer drug research.Clin Transl Oncol. 2007 Apr;9(4):221-8. doi: 10.1007/s12094-007-0043-2. Clin Transl Oncol. 2007. PMID: 17462974 Review.
-
Yeast as a drug discovery platform in Huntington's and Parkinson's diseases.Biotechnol J. 2006 Mar;1(3):258-69. doi: 10.1002/biot.200500043. Biotechnol J. 2006. PMID: 16897706 Review.
Cited by
-
Profiling the physiological pitfalls of anti-hepatitis C direct-acting agents in budding yeast.Microb Biotechnol. 2021 Sep;14(5):2199-2213. doi: 10.1111/1751-7915.13904. Epub 2021 Aug 11. Microb Biotechnol. 2021. PMID: 34378349 Free PMC article.
-
Role of heme in the antifungal activity of the azaoxoaporphine alkaloid sampangine.Eukaryot Cell. 2008 Feb;7(2):387-400. doi: 10.1128/EC.00323-07. Epub 2007 Dec 21. Eukaryot Cell. 2008. PMID: 18156292 Free PMC article.
-
Genome wide screens in yeast to identify potential binding sites and target genes of DNA-binding proteins.Nucleic Acids Res. 2008 Jan;36(1):e8. doi: 10.1093/nar/gkm1117. Epub 2007 Dec 17. Nucleic Acids Res. 2008. PMID: 18086703 Free PMC article.
-
Procarcinogens - Determination and Evaluation by Yeast-Based Biosensor Transformed with Plasmids Incorporating RAD54 Reporter Construct and Cytochrome P450 Genes.PLoS One. 2016 Dec 22;11(12):e0168721. doi: 10.1371/journal.pone.0168721. eCollection 2016. PLoS One. 2016. PMID: 28006013 Free PMC article.
-
A potent plant-derived antifungal acetylenic acid mediates its activity by interfering with fatty acid homeostasis.Antimicrob Agents Chemother. 2012 Jun;56(6):2894-907. doi: 10.1128/AAC.05663-11. Epub 2012 Mar 19. Antimicrob Agents Chemother. 2012. PMID: 22430960 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Molecular Biology Databases